BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11243857)

  • 1. Analysis of molecular interactions of the p53-family p51(p63) gene products in a yeast two-hybrid system: homotypic and heterotypic interactions and association with p53-regulatory factors.
    Kojima T; Ikawa Y; Katoh I
    Biochem Biophys Res Commun; 2001 Mar; 281(5):1170-5. PubMed ID: 11243857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 gene family p51(p63)-encoded, secondary transactivator p51B(TAp63alpha) occurs without forming an immunoprecipitable complex with MDM2, but responds to genotoxic stress by accumulation.
    Okada Y; Osada M; Kurata S; Sato S; Aisaki K; Kageyama Y; Kihara K; Ikawa Y; Katoh I
    Exp Cell Res; 2002 Jun; 276(2):194-200. PubMed ID: 12027449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated transfer of p53-related genes induces apoptosis of human cancer cells.
    Ishida S; Yamashita T; Nakaya U; Tokino T
    Jpn J Cancer Res; 2000 Feb; 91(2):174-80. PubMed ID: 10761704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of viral oncoproteins to target the p53-homologue p51A.
    Roth J; Dobbelstein M
    J Gen Virol; 1999 Dec; 80 ( Pt 12)():3251-3255. PubMed ID: 10567658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging p53 gene family.
    Kaelin WG
    J Natl Cancer Inst; 1999 Apr; 91(7):594-8. PubMed ID: 10203277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of p51/p63 missense mutations on transcriptional activities of p53 downstream gene promoters.
    Kato S; Shimada A; Osada M; Ikawa S; Obinata M; Nakagawara A; Kanamaru R; Ishioka C
    Cancer Res; 1999 Dec; 59(23):5908-11. PubMed ID: 10606233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel retrovirus long terminal repeat (LTR) that is targeted by p51A (TAp63gamma) and selective dominant-negative activity of p73L (DeltaNp63alpha) toward p53-responsive promoter activities.
    Senoo M; Matsumura Y; Habu S
    Biochem Biophys Res Commun; 2001 Aug; 286(3):628-34. PubMed ID: 11511106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53.
    Davison TS; Vagner C; Kaghad M; Ayed A; Caput D; Arrowsmith CH
    J Biol Chem; 1999 Jun; 274(26):18709-14. PubMed ID: 10373484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53CP is p51/p63, the third member of the p53 gene family: partial purification and characterization.
    Tan M; Bian J; Guan K; Sun Y
    Carcinogenesis; 2001 Feb; 22(2):295-300. PubMed ID: 11181451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDM2 and MDMX can interact differently with ARF and members of the p53 family.
    Wang X; Arooz T; Siu WY; Chiu CH; Lau A; Yamashita K; Poon RY
    FEBS Lett; 2001 Feb; 490(3):202-8. PubMed ID: 11223036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E1B 55-kilodalton oncoproteins of adenovirus types 5 and 12 inactivate and relocalize p53, but not p51 or p73, and cooperate with E4orf6 proteins to destabilize p53.
    Wienzek S; Roth J; Dobbelstein M
    J Virol; 2000 Jan; 74(1):193-202. PubMed ID: 10590106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of the p51/p63 gene is associated with blastic crisis in chronic myelogenous leukemia.
    Yamaguchi H; Inokuchi K; Sakuma Y; Dan K
    Leukemia; 2001 Nov; 15(11):1729-34. PubMed ID: 11681414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.
    Gaiddon C; Lokshin M; Ahn J; Zhang T; Prives C
    Mol Cell Biol; 2001 Mar; 21(5):1874-87. PubMed ID: 11238924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and functional analysis of human p51, which structurally and functionally resembles p53.
    Osada M; Ohba M; Kawahara C; Ishioka C; Kanamaru R; Katoh I; Ikawa Y; Nimura Y; Nakagawara A; Obinata M; Ikawa S
    Nat Med; 1998 Jul; 4(7):839-43. PubMed ID: 9662378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p53 gene family.
    Kaelin WG
    Oncogene; 1999 Dec; 18(53):7701-5. PubMed ID: 10618710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73.
    Zdzalik M; Pustelny K; Kedracka-Krok S; Huben K; Pecak A; Wladyka B; Jankowski S; Dubin A; Potempa J; Dubin G
    Cell Cycle; 2010 Nov; 9(22):4584-91. PubMed ID: 21088494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation and activation of p53 and its family members.
    Lohrum MA; Vousden KH
    Cell Death Differ; 1999 Dec; 6(12):1162-8. PubMed ID: 10637431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p51A (TAp63gamma), a p53 homolog, accumulates in response to DNA damage for cell regulation.
    Katoh I; Aisaki KI; Kurata SI; Ikawa S; Ikawa Y
    Oncogene; 2000 Jun; 19(27):3126-30. PubMed ID: 10871867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAp63gamma (p51A) and dNp63alpha (p73L), two major isoforms of the p63 gene, exert opposite effects on the vascular endothelial growth factor (VEGF) gene expression.
    Senoo M; Matsumura Y; Habu S
    Oncogene; 2002 Apr; 21(16):2455-65. PubMed ID: 11971180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homolog p63.
    CalabrĂ² V; Mansueto G; Parisi T; Vivo M; Calogero RA; La Mantia G
    J Biol Chem; 2002 Jan; 277(4):2674-81. PubMed ID: 11714701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.